The U.S. Market for Over-the-Counter Gastrointestinal Products, 2nd Edition

 
   Single User - $1,995
   Corporate License - $5,990


Loading...
Published Aug 1, 2004 | 176 Pages | Pub ID: KLI969294

The market for OTC Gastrointestinal products has gone through several significant changes in the past 5 years, most of which have to do with the Rx-to-OTC switches of two types of gastroesophageal reflux disease (GERD) drugs: H2 receptor antagonists and proton pump inhibitors (PPIs).

This report on the U.S. market for OTC GI products presents a description of upper gastrointestinal conditions and diseases, the OTC treatments available, and clinical and business trends affecting the market, consumer behavior and attitudes, and promotional activities in the sector. The report details OTC GI products addressing ailments such as stomach upset, diarrhea, ulcers, and heartburn (gastroesophageal reflux).

The report provides a comprehensive analysis of the GI products that are currently marketed and those that are likely to enter the market in future. The study focuses on the direction the market is moving and the factors that will fuel sustainable growth. Trends covered in the report include consumer usage of tablets and liquids, dual regulatory status, consumer interest in self-medication and the impact of direct-to-consumer advertising. The report also discusses the consumer behavior in the United States toward OTC GI drugs.

The report provides sales data and market share in information on a range of OTC GI products and forecasts sales to 2008, while outlining the key market factors and the expected future trends in each category. For the purposes of this study, OTC GI products have been categorized into the following six generic groups:

  • Antacids
  • H2 Receptor Antagonists
  • Proton Pump Inhibitors (PPI)
  • Laxatives
  • Antidiarrheals
  • Stomach remedies

The report also analyzes the industry as a whole, while exploring its relationship with various traditional healthcare delivery channels. The report also provides the profiles of key players operating in the market.

CHAPTER ONE: EXECUTIVE SUMMARY
  • Scope
  • Methodology
  • Market Overview
  • Market Players
  • Top Brands
  • Key Issues and Trends
    • The HMO Threat
    • Growing Healthcare Costs
    • FDA Regulations
    • Opportunity in Off-Patent Drugs
    • Increasing Consumer Awareness

  • Outlook

CHAPTER TWO: INTRODUCTION

  • Overview of the Upper GI System
  • Upper GI Diseases and Conditions
    • Gastritis
    • GERD (Gastro Esophageal Reflux Disease)
    • Heartburn and Indigestion
    • Peptic Ulcers
    • Gastric Ulcers
    • Duodenal Ulcers

  • GI Products
    • Antacids
    • H2 Receptor Antagonists
    • PPIs
    • Laxatives
    • Antidiarrheals
    • Stomach Remedies

CHAPTER THREE: THE MARKET

  • Market Structure
    • The U.S. Food and Drug Administration
    • Pharmaceutical Companies
    • HMOs
    • The Consumer

  • Key Growth Factors
    • Rx-to-OTC Switches
    • Dual Regulatory Status
    • Revenue Protection
    • Importance of Establishing a Global Brand

  • Key Issues and Trends
    • Increasing Percentage of the Elderly Population
    • Direct-to-consumer Advertising
    • Consolidation in the OTC Market
    • The Online Healthcare Market
    • Consumer Acceptance of Self-Medication
    • The Insurer Push
    • Reimportation of Drugs

  • Market Composition
  • Market Projections
  • International Trends in OTC Market

CHAPTER FOUR: MARKET SEGMENTS

  • Traditional Antacids
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

  • H2 Receptor Antagonists
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

  • Proton Pump Inhibitors
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

  • Laxatives
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

  • Antidiarrheals
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

  • Stomach Remedies
    • Market Growth
    • Product Description
    • Rx-to-OTC Switches
    • Generic Participation

CHAPTER FIVE: MARKET PLAYERS

  • >Key Market Players
  • Traditional Antacids
    • Market Size and Share
    • Competitive Analysis

  • H2 Receptor Antagonists
    • Market Size and Share
    • Competitive Analysis

  • Proton Pump Inhibitors
    • Market Size and Share
    • Competitive Analysis

  • Laxatives
    • Market Size and Share
    • Competitive Analysis

  • Antidiarrheals
    • Market Size and Share
    • Competitive Analysis

  • Stomach Remedies
    • Market Size and Share
    • Competitive Analysis

CHAPTER SIX: THE CONSUMER

  • Overview
  • Methodology
  • Indigestion Drugs
    • Age-wise Use
    • Income-wise Use
    • Race-wise Use
    • Region-wise Use
    • Other Prime Users
    • Most Frequent Users

  • Laxatives
    • Age-wise Use
    • Income-wise Use
    • Race-wise Use
    • Region-wise Use
    • Other Prime Users
    • Most Frequent Users

  • Choice of OTC brands
    • Popular Indigestion Drugs Brands
    • Main Users of Tums
    • Main Users of Pepto-Bismol
    • Popular Laxative Brands
    • Main Users of Ex Lax
    • Main Users of Metamucil
    • Forms Favored: Chewable Tablets, Liquids, Caplets
    • Main Users of Chewable Tablets
    • Main Users of Regular Liquids
    • Main Users of Caplets

  • Consumer Attitudes
    • Main Users of Fruit Flavor
    • Prime Users of Non-Flavor
    • Main Users of Mint Flavor
    • The Ingredient Examining Trend
    • The Safety Factor: OTC Vs Prescription

CHAPTER SEVEN: ADVERTISING AND RETAILING

  • Overview
  • Big-Budget Brands
  • Big Spenders
  • Ad Spends on New products & Line extensions
  • Online Promotions
  • Retailing Structure
    • Wholesalers
    • Drug Store Chains
    • e-Pharmacies

  • Retail Promotions
  • The FDA- Promotional Guidelines and Labeling Issues
    • Direct-To-Consumer Advertising

CHAPTER EIGHT: COMPANY PROFILES

  • Procter & Gamble
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis
  • Pfizer Inc
  • Bayer Corporation
  • Purdue Pharma LP
  • C.B. Fleet
  • Wyeth
  • IVAX Corporation
  • Perrigo Company

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER THREE: THE MARKET

  • Figure 3-1: OTC Review Process
  • Figure 3-2: A typical OTC Label
  • Table 3-1: OTC GI Rx-to-OTC Switches by Supplier, 1995-2000
  • Table 3-2: Projections: Number of Dependants per 100 persons
  • Table 3-3: Market Segments and Size OTC GI Market
  • Figure 3-3: Segment-wise Market Share of US OTC GI Subcategories in 2003
  • Table 3-4: US OTC GI Products: Liquids vs Tablets
  • Figure 3-4: Projections for the OTC GI Liquids Market
  • Figure 3-5: Projections for the OTC GI Tablets Market
  • Figure 3-6: Projected Sales of US OTC GI Products

CHAPTER FOUR: MARKET SEGMENTS

  • Table 4-1: Leading Antacid Brands in the US: Tablets, 2003
  • Table 4-2: Leading Antacid Brands in the US: Liquids, 2003
  • Figure 4-1: Projected Growth of the US Antacid Segment
  • Table 4-3: Leading H2 Receptor Brands in the US: Tablets, 2003
  • Figure 4-2: Projected Growth of the US H2 Receptor Antagonist Segment
  • Table 4-4: Leading Laxative Brands: Tablets, 2003
  • Table 4-5: Leading Laxative Brands: Liquids, 2003
  • Table 4-6: Projected Growth of the US Laxatives Market
  • Table 4-7: Leading Antidiarrheals Brands: Tablets, 2003
  • Table 4-8: Leading Antidiarrheals Liquid / Powder Brands, 2003
  • Figure 4-4: Projected Growth of the US Antidiarrheals Market
  • Table 4-9: Leading OTC Stomach Remedies Brands, 2003
  • Figure 4-5: Projected Growth of the US Stomach Remedies Market

CHAPTER FIVE: MARKET PLAYERS

  • Table 5-1: OTC Leading GI Products Players, 2003
  • Table 5-2: Leading Players’ OTC GI Growth 2002-2003
  • Table 5-3: Leading OTC Antacid Brands in 2003
  • Table 5-4: Growth of Leading OTC Antacid Products 2002-2003
  • Table 5-5: Leading OTC H2 Receptor Antagonists Brands, 2003
  • Table 5-6: Growth of Leading OTC H2 Receptor Antagonists 2002-2003
  • Table 5-7: Leading OTC Laxatives Brands, 2003
  • Table 5-8: Growth of Leading OTC Laxatives Products 2002-2003
  • Table 5-9: Leading OTC Antidiarrheals Brands, 2003
  • Table 5-10: Growth of Leading OTC Antidiarrheals Brands 2002-2003
  • Table 5-11: Leading OTC Stomach Remedies Brands, 2003
  • Table 5-12: OTC Growth of Leading Stomach Remedies Brands 2002-2003
  • Table 5-13: Product Introductions in the OTC GI Market (January 2003- March 2004)

CHAPTER SIX: THE CONSUMER

  • Figure 6-1: Reasons for Use of OTC Indigestion Aids
  • Figure 6-2: Gender-wise Use of OTC Indigestion Drugs
  • Figure 6-3: Age-wise Use of OTC Indigestion Drugs
  • Figure 6-4: Income-wise Use of OTC Indigestion Drugs
  • Figure 6-5: Race-wise Use of OTC Indigestion Drugs
  • Figure 6-6: Region-wise Use of OTC Indigestion Drugs
  • Table 6-1: Demographic Features of US Adults Favoring Indigestion Drug Use
  • Table 6-2: Gender-wise Frequency of OTC Indigestion Drugs Use Among U.S. Adults
  • Table 6-3: Demographic Features of US Adults Using Indigestion Drugs Very frequently
  • Figure 6-7: Gender-wise Use of Laxatives
  • Figure 6-8: Age-wise Use of Laxatives
  • Figure 6-9: Income-wise Use of Laxatives
  • Figure 6-10: Race-wise Use of Laxatives
  • Figure 6-11: Region-wise Use of Laxatives
  • Table 6-4: Demographic Features of US Adults Favoring Laxative Use
  • Table 6-5: Gender-wise Frequency of Laxatives Use Among US Adults (%)
  • Table 6-6: Demographic Features of US Adults Very Frequently Using Laxatives
  • Figure 6-12: Popular Indigestion Drugs
  • Table 6-7: Demographic Features of US Adults Favoring Tums
  • Table 6-8: Demographic Features of US Adults Favoring Pepto-Bismol
  • Figure 6-13: Popular Laxative Brands
  • Table 6-9: Demographic Features of US Adults Favoring Ex Lax
  • Table 6-10: Demographic Features of US Adults Favoring Metamucil
  • Figure 6-14: Preferred Forms of OTC Indigestion Drugs
  • Table 6-11: Demographic Features of US Adults Favoring Chewable Tablets
  • Table 6-12: Demographic Features of US Adults Favoring Liquids
  • Table 6-13: Demographic Features of US Adults Favoring Caplets
  • Figure 6-15: Preferred Flavors of Indigestion Drugs
  • Table 6-14: Demographic Features of US Adults Preferring Fruit Flavor
  • Table 6-15: Demographic Features of US Adults Favoring Non-Flavor Drugs
  • Table 6-16: Demographic Features of US Adults Favoring Mint Flavor
  • Table 6-17: Demographics of US Adults Who Examine Ingredients of the Drug Before Buying
  • Table 6-18: Demographics of US Adults who Feel OTC Drugs are Safer Than Prescription Drugs

CHAPTER SEVEN: ADVERTISING AND RETAILING

  • Table 7-1: Top Ten Brands by Advertising Spends
  • Figure 7-1 Advertising Spends of Major Manufacturers
  • Table 7-2: The Big Ad Spenders
  • Table 7-3: Ad Spends on New Products and Line Extensions
  • Figure 7-2: The Controversial Prilosec Advertisement

CHAPTER EIGHT: COMPANY PROFILES
  • Table 8-1: Top-10 Players’ Brand Sales in 2003